Chennai, India – October 16, 2024 : Biodimension Technology
Private Limited, a cutting-edge deep tech startup focused on human tissue
and organ development, has successfully closed a ₹121 lakh funding round led by
Campus Angels Network. This
investment will accelerate Biodimension’s mission to revolutionize the
healthcare and pharmaceutical industries with innovative tissue models that
enable more efficient, ethical, and human-relevant testing for drug and
cosmetic safety.
Founded in 2021 by Manoj Kumar
Sampath (CEO), Ranjith
Kumar Velusamy (Chief Innovation Officer), and Pradeep Arunachalam
(Chief Operating Officer), Biodimension Technology has rapidly emerged as a
leader in biofabrication technology. The company develops functional replicas
of human tissues to serve as a platform for drug, chemical, and cosmetic
testing. Their products provide an ethical alternative to animal testing,
addressing significant challenges in pharmaceutical R&D and meeting the
growing global demand for cruelty-free testing methods.
Leadership Insights
Manoj Kumar, Co-Founder & CEO of
Biodimension Technology, shared, “This funding marks a pivotal moment in our
journey to redefine drug testing and healthcare innovation. With the support of
Campus Angels Network, we are now positioned to scale our operations and expand
the reach of our human tissue models. Our goal is to provide pharmaceutical and
cosmetic industries with advanced testing platforms that offer more reliable,
human-relevant data.”
Chandran
Krishnan, Managing Director & CEO of Campus Angels Network, emphasized,
“Biodimension’s innovative approach to biofabrication aligns perfectly with our
philosophy of supporting deep tech startups that have a transformative impact.
Their human tissue models not only offer a sustainable alternative to animal
testing but also have the potential to greatly enhance the accuracy of
pharmaceutical research and product testing. We are thrilled to partner with
them on this exciting journey.”
Strategic Growth
The funding will be utilized to
enhance Biodimension’s cleanroom facilities, ramp up product development, and
expand marketing efforts to increase adoption of its tissue models. This
investment will further solidify Biodimension’s position as a leader in the
rapidly growing non-animal testing market, positioning it for long-term growth
and success in both the pharmaceutical and cosmetic industries.
About Biodimension Technology
Biodimension Technology is a
biotechnology company incubated by Vellore
Institute of Technology TBI and Sastra
ABLEST. The company develops human tissue models using advanced
biofabrication technologies, providing a platform for more ethical and accurate
testing in drug development, cosmetics, and other industries.